Protective or limited? Maternal antibodies and RSV-associated lower respiratory tract infection in hospitalized infants aged 28-90 days
BackgroundRespiratory syncytial virus (RSV) is a major cause of severe health problems in newborns and young children. The protective role and limitations of serum maternal RSV antibodies in infants under 3 months remain controversial.MethodsA two-center prospective study from 2020 to 2023 recruited...
Saved in:
Main Authors: | Shuanglian Li, Chenghao Mei, Sainan Chen, Chenglin Wang, Yelei Gao, Jinhua Ma, Li Zhong, Tingting Luo, Xin Zhao, Huaqin Bu, Ying Lyu, Xiaohu Kuang, Zhenxing Jia, Xiaoli Wang, Yuqing Wang, Daiyin Tian |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-01-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2024.1437616/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Characteristics of the First Italian Older Adults Vaccinated with an Adjuvanted Respiratory Syncytial Virus (RSV) Vaccine
by: Alexander Domnich, et al.
Published: (2025-01-01) -
Anti-Idiotypic Antibody as a Booster Vaccine Against Respiratory Syncytial Virus
by: Shreya Mukhopadhyay, et al.
Published: (2025-01-01) -
Identification of rare anti-f alloantibody in a tertiary care center in India
by: Gunjan Bhardwaj, et al.
Published: (2024-01-01) -
Maternal F1 antibodies and cytokines in mother-neonate dog pairs in the Marmota himalayana plague focus
by: Deming Tang, et al.
Published: (2025-02-01) -
Economic and Clinical Benefits of Bivalent Respiratory Syncytial Virus Prefusion F (RSVpreF) Maternal Vaccine for Prevention of RSV in Infants: A Cost-Effectiveness Analysis for Mexico
by: José Luis Huerta, et al.
Published: (2025-01-01)